| LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease C Yao, R El Khoury, W Wang, TA Byrd, EA Pehek, C Thacker, X Zhu, ... Neurobiology of disease 40 (1), 73-81, 2010 | 143 | 2010 |
| Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity C Yao, WM Johnson, Y Gao, W Wang, J Zhang, M Deak, DR Alessi, X Zhu, ... Human molecular genetics 22 (2), 328-344, 2013 | 90 | 2013 |
| Vitamin B12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection A Schaffner, X Li, Y Gomez-Llorente, E Leandrou, A Memou, N Clemente, ... Cell research 29 (4), 313-329, 2019 | 59 | 2019 |
| Glutaredoxin deficiency exacerbates neurodegeneration in C. elegans models of Parkinson's disease WM Johnson, C Yao, SL Siedlak, W Wang, X Zhu, GA Caldwell, ... Human molecular genetics 24 (5), 1322-1335, 2015 | 53 | 2015 |
| Regulation of DJ-1 by glutaredoxin 1 in vivo: implications for Parkinson’s disease WM Johnson, M Golczak, K Choe, PL Curran, OG Miller, C Yao, W Wang, ... Biochemistry 55 (32), 4519-4532, 2016 | 38 | 2016 |
| Quantitative determination of helicid in rat biosamples by liquid chromatography electrospray ionization mass spectrometry Y Jia, H Xie, G Wang, J Sun, W Wang, H Qing, X Wang, H Yang, M Xu, ... Journal of Chromatography B 878 (9-10), 791-797, 2010 | 15 | 2010 |
| Quantitative determination of helicid in rat plasma by liquid chromatography–electrospray ionization mass spectrometry and its application to preliminary pharmacokinetic studies Y Jia, G Wang, H Xie, X Dai, Y Wang, W Wang, M Xu, R Wang, C Yao Journal of Chromatography B 847 (2), 72-77, 2007 | 14 | 2007 |
| Loss of redoxin proteins exacerbates LRRK2‐mediated Parkinson's disease phenotype in C. elegans WM Johnson, C Yao, S Chen, AL Wilson‐Delfosse, JJ Mieyal The FASEB Journal 27, 558.4-558.4, 2013 | 1 | 2013 |
